Focus: Vivex Biologics is a tissue-based biotechnology company focused on regenerative medicine solutions, with a pipeline centered on allograft technologies for musculoskeletal and degenerative disc indications. The company operates from Atlanta with a lean team structure and early-stage clinical programs.
Profile data last refreshed 2h ago · AI intelligence enriched 2w ago
Stable — net -3 jobs in 30d
5 added, 8 removed. Backfill posture.
Vivex is a high-risk, early-stage regenerative medicine play best suited for candidates seeking founding-team exposure and tissue engineering expertise, but with significant uncertainty on financing and clinical progression.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Vivex Biologics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Vivex Biologics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
Hemp-Derived Extracellular Vesicles: A Novel Frontier in Nanomedicine and Therapeutics.
Nucleus Pulposus Allograft Supplementation in Patients with Lumbar Discogenic Pain: Initial 6-month Outcomes from a Prospective Clinical Pilot Study.
Showing 5 of 7 publications